| Product Code: ETC13167022 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Pharmaceutical Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Pharmaceutical Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Pharmaceutical Market - Industry Life Cycle |
3.4 Europe Pharmaceutical Market - Porter's Five Forces |
3.5 Europe Pharmaceutical Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2021 & 2031F |
3.7 Europe Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Europe Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.9 Europe Pharmaceutical Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Europe Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.11 Europe Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Europe Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Pharmaceutical Market Trends |
6 Europe Pharmaceutical Market, 2021 - 2031 |
6.1 Europe Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Pharmaceutical Market, Revenues & Volume, By Prescription Drugs, 2021 - 2031 |
6.1.3 Europe Pharmaceutical Market, Revenues & Volume, By Over-the-Counter Drugs, 2021 - 2031 |
6.2 Europe Pharmaceutical Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Pharmaceutical Market, Revenues & Volume, By Branded Drugs, 2021 - 2031 |
6.2.3 Europe Pharmaceutical Market, Revenues & Volume, By Generic Drugs, 2021 - 2031 |
6.2.4 Europe Pharmaceutical Market, Revenues & Volume, By Branded Generic Drugs, 2021 - 2031 |
6.3 Europe Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Pharmaceutical Market, Revenues & Volume, By Small Molecules, 2021 - 2031 |
6.3.3 Europe Pharmaceutical Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.3.4 Europe Pharmaceutical Market, Revenues & Volume, By Biosimilars, 2021 - 2031 |
6.4 Europe Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Pharmaceutical Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.4.3 Europe Pharmaceutical Market, Revenues & Volume, By Immunology, 2021 - 2031 |
6.4.4 Europe Pharmaceutical Market, Revenues & Volume, By Respiratory Diseases, 2021 - 2031 |
6.4.5 Europe Pharmaceutical Market, Revenues & Volume, By Neurological Diseases, 2021 - 2031 |
6.4.6 Europe Pharmaceutical Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.4.7 Europe Pharmaceutical Market, Revenues & Volume, By Skin Diseases, 2021 - 2031 |
6.5 Europe Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Europe Pharmaceutical Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.5.3 Europe Pharmaceutical Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.5.4 Europe Pharmaceutical Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.5.5 Europe Pharmaceutical Market, Revenues & Volume, By Intra-nasal, 2021 - 2031 |
6.5.6 Europe Pharmaceutical Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Europe Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Europe Pharmaceutical Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.6.3 Europe Pharmaceutical Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.6.4 Europe Pharmaceutical Market, Revenues & Volume, By Drug Stores, 2021 - 2031 |
6.6.5 Europe Pharmaceutical Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
7 Europe Pharmaceutical Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
7.2.2 Germany Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
7.2.3 France Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
7.2.4 Poland Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
7.2.5 Spain Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
7.2.6 Rest of Europe Pharmaceutical Market, Revenues & Volume, By Prescription Type, 2021 - 2031 |
7.3 Europe Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) Pharmaceutical Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3.2 Germany Pharmaceutical Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3.3 France Pharmaceutical Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3.4 Poland Pharmaceutical Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3.5 Spain Pharmaceutical Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3.6 Rest of Europe Pharmaceutical Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4 Europe Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.1 United Kingdom (UK) Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.2 Germany Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.3 France Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.4 Poland Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.5 Spain Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4.6 Rest of Europe Pharmaceutical Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.5 Europe Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5.1 United Kingdom (UK) Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5.2 Germany Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5.3 France Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5.4 Poland Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5.5 Spain Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5.6 Rest of Europe Pharmaceutical Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.6 Europe Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.6.1 United Kingdom (UK) Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.6.2 Germany Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.6.3 France Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.6.4 Poland Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.6.5 Spain Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.6.6 Rest of Europe Pharmaceutical Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.7 Europe Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.1 United Kingdom (UK) Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.2 Germany Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.3 France Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.4 Poland Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.5 Spain Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.6 Rest of Europe Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Europe Pharmaceutical Market Key Performance Indicators |
9 Europe Pharmaceutical Market - Export/Import By Countries Assessment |
10 Europe Pharmaceutical Market - Opportunity Assessment |
10.1 Europe Pharmaceutical Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2021 & 2031F |
10.3 Europe Pharmaceutical Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.4 Europe Pharmaceutical Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.5 Europe Pharmaceutical Market Opportunity Assessment, By Indication, 2021 & 2031F |
10.6 Europe Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10.7 Europe Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Europe Pharmaceutical Market - Competitive Landscape |
11.1 Europe Pharmaceutical Market Revenue Share, By Companies, 2022 |
11.2 Europe Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here